Related Experiment Videos
Interventions for treating bacterial vaginosis in pregnancy
P Brocklehurst1, M Hannah, H McDonald
1National Perinatal Epidemiology Unit, Institute of Health Sciences, Old Road, Headington, Oxford, UK, OX3 7LF. peter.brocklehurst@perinat.ox.ac.uk
The Cochrane Database of Systematic Reviews
|May 5, 2000
Summary
Antibiotic treatment effectively eradicates bacterial vaginosis in pregnant women. However, current evidence does not support routine screening for all, though it may benefit women with a history of preterm birth.
Area of Science:
- Obstetrics and Gynecology
- Infectious Diseases
- Perinatal Medicine
Background:
- Bacterial vaginosis (BV) is linked to adverse perinatal outcomes.
- Treatment of BV during pregnancy may mitigate risks like preterm birth.
Purpose of the Study:
- To evaluate the impact of antibiotic treatment for bacterial vaginosis in pregnant individuals.
Main Methods:
- Systematic review of randomized controlled trials (RCTs).
- Searched Cochrane Pregnancy and Childbirth Group and Cochrane Controlled Trials Registers.
- Included trials comparing antibiotic regimens with placebo or no treatment.
Main Results:
- Five high-quality trials involving 1504 women were analyzed.
- Antibiotic therapy demonstrated high efficacy in eradicating BV during pregnancy.
- A trend towards reduced preterm births (<37 weeks) was observed, particularly in women with prior preterm birth history.
Conclusions:
- Routine screening and treatment of BV in all pregnant women is not currently supported by evidence.
- BV treatment may offer benefits for women with a history of preterm birth.
- The impact on neonatal well-being remains undetermined.